Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Cécile Nozières"'
Autor:
Véronique Lapras, Françoise Borson-Chazot, Lucien Marchand, Myriam Decaussin-Petrucci, Marie-Odile Joly, Cécile Nozières, Thomas Walter, Claire Bournaud, Françoise Descotes
Publikováno v:
Acta oncologica (Stockholm, Sweden). 55(8)
Autor:
Cécile Nozières, Karim Chikh, Françoise Borson-Chazot, Bernard Goichot, Laurence Chardon, Valérie Hervieu, Thomas Walter, Catherine Lombard-Bohas
Publikováno v:
European Journal of Endocrinology
European Journal of Endocrinology, BioScientifica, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩
European Journal of Endocrinology, BioScientifica, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩
ObjectivesInappropriate calcitonin (CT) release, a major feature of medullary thyroid cancer (MTC), may occur in neuroendocrine tumors (NETs). The aims of this retrospective study were to assess i) the characteristics and prognosis of CT-producing NE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f564d700d8f08915a69aa17893f54fa3
https://hal.archives-ouvertes.fr/hal-01850353
https://hal.archives-ouvertes.fr/hal-01850353
Publikováno v:
Annales d'Endocrinologie. 72:198-202
Thyroid consequences of cancer therapy are multiple, better known after radiotherapy than after chemotherapy and recently described with targeted therapies. Cervical or total body irradiation may result in thyroid insufficiency or cancer. The consequ
Publikováno v:
Annales d'Endocrinologie. 77:668-669
Autor:
Marine Guillaud-Bataille, Marie-Françoise Odou, Martine Cordier-Bussat, Catherine Cardot-Bauters, Philippe Ruszniewski, Valérie Hervieu, C.X. Zhang, Marie-Odile Joly, Sophie Giraud, Rosa Vargas-Poussou, Cécile Nozières, Alexandre Buffet, Alain Calender, Delphine Vezzosi, Pierre Goudet, Anne-Paule Gimenez-Roqueplo, Sophie Christin-Maitre, Stephanie Dupasquier, Lionel Groussin, Françoise Borson-Chazot, Arnaud Murat, Groupe français des tumeurs endocrines
Publikováno v:
Annales d'Endocrinologie
Annales d'Endocrinologie, 2014, 75 (3), pp.133-140. ⟨10.1016/j.ando.2014.05.003⟩
Annales d'Endocrinologie, Elsevier Masson, 2014, 75 (3), pp.133-140. ⟨10.1016/j.ando.2014.05.003⟩
Annales d'Endocrinologie, 2014, 75 (3), pp.133-140. ⟨10.1016/j.ando.2014.05.003⟩
Annales d'Endocrinologie, Elsevier Masson, 2014, 75 (3), pp.133-140. ⟨10.1016/j.ando.2014.05.003⟩
International audience; ContextMultiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant inherited syndrome, related to mutations in the MEN1 gene. Controversial data suggest that the nonsynonymous p.Ala541Thr variant, usually considered as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aef77d82d36b315f0761a50a3cfe6cd
https://univ-angers.hal.science/hal-03276624
https://univ-angers.hal.science/hal-03276624
Publikováno v:
Annales d'Endocrinologie. 76:355-356
Introduction Les inhibiteurs de tyrosine kinase (ITK) sont maintenant indiques en premiere intention dans les formes agressives et symptomatiques de cancer medullaire de la thyroide (CMT) avance. Cependant, le recours a la chimiotherapie peut se just
Autor:
Eric Baudin, François Pattou, Clement Mazoyer, Jérôme Bertherat, Sébastien Aubert, Ghuzlan Abir Al, Cécile Nozières, Françoise Borson-Chazot, Sophie Leboulleux, Ludovic Lacroix, Cao Christine Do, Jean-Yves Scoazec, Guillaume Assié, Rosario Pivonello, Martino Maria Cristina De, Rossella Libe, Martin Schlumberger
Publikováno v:
Endocrine Abstracts.
Autor:
Isabelle Borget, Françoise Borson-Chazot, Eric Baudin, Annamaria Colao, Maria Cristina De Martino, Jean-Yves Scoazec, Martin Schlumberger, Ludovic Lacroix, Abir Al Ghuzlan, Rosario Pivonello, Jean-Charles Soria, Ségolène Hescot, Guillaume Assié, Marc Lombès, Clement Mazoyer, Jacques Young, Christine Do Cao, Sophie Leboulleux, Jérôme Bertherat, Cécile Nozières, Sébastien Aubert, François Pattou, Rossella Libé
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (10), pp.4080-4088. ⟨10.1210/jc.2013-2165⟩
Journal of Clinical Endocrinology and Metabolism, 2013, 98 (10), pp.4080-4088. ⟨10.1210/jc.2013-2165⟩
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (10), pp.4080-4088. ⟨10.1210/jc.2013-2165⟩
Journal of Clinical Endocrinology and Metabolism, 2013, 98 (10), pp.4080-4088. ⟨10.1210/jc.2013-2165⟩
Context: Adrenocortical cancer (ACC) is a rare cancer with poor prognosis and scant treatment options. In ACC, no personalized approach has emerged but no extensive molecular screening has been performed to date. Objective: The objective of the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0209ca6ec998763777b58929d7071715
http://hdl.handle.net/11588/569198
http://hdl.handle.net/11588/569198
Autor:
Sophie Giraud, Cécile Nozières, Chantal Simon, Catherine Lombard-Bohas, Thomas Walter, Françoise Borson-Chazot, Marie-Odile Joly, Jean-Paul Riou, Jean-Yves Scoazec
Publikováno v:
European journal of endocrinology. 166(6)
Ten percent of paragangliomas are malignant and one-third occurs in a genetic background. We report a case of succinate dehydrogenase subunit B (SDHB)-related malignant paraganglioma with dramatic response to temozolomide and capecitabine regimen (de
Autor:
Cécile Nozières, Pascale Berlier, Catherine Raynaud-Ravni, Marc Nicolino, Françoise Borson Chazot, Yves Morel, Clémentine Dupuis
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 6, Iss 1, p 67 (2011)
Orphanet Journal of Rare Diseases, Vol 6, Iss 1, p 67 (2011)
Background Somatotropinoma, a pituitary adenoma characterised by excessive production of growth hormone (GH), is extremely rare in childhood. A genetic defect is evident in some cases; known genetic changes include: multiple endocrine neoplasia type